KSF News, Updates, & Insights

Preliminary Approval of Settlement in Intellipharmaceutics Litigation

On July 30, 2020, the Hon. J. Paul Oetken, United States District Court Judge for the Southern District of New York, entered an Order preliminarily approving a $1,600,000 class action settlement on behalf of all Persons or entities who purchased or otherwise acquired Intellipharmaceutics common stock in a Covered Transaction at any time from May 21, 2015 through and including July 27, 2017. For more information regarding the proposed settlement, KSF directs investors to the dedicated website, https://intellipharmaceuticssecuritieslitigation.com/. A copy of the Complaint and the Stipulation (including Exhibits) are available below: